Great News
Excerpt from today's NR:
"Management anticipates that discussions with NCI will be ongoing as the Company's development of GAP-107B8 continues, and significant outcomes of these discussions, and additional data from this testing program, will be announced as they become known and are fully analyzed by the Company".
Looks like NCI are on board with further testing i.e. we have passed the magical 2% mark.